Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Outcome Measure:

The increase in Hb concentration

Outcome Time Frame:

week 8

Safety Issue:

No

Principal Investigator

Yoshiharu Ishikura

Investigator Role:

Study Director

Investigator Affiliation:

Chugai Pharmaceutical

Authority:

Japan: Ministry of Health, Labor and Welfare

Study ID:

EPO307JP

NCT ID:

NCT00144482

Start Date:

December 2003

Completion Date:

August 2005

Related Keywords:

• Chemotherapy Induced Anemia
• Anemia